Results 111 to 120 of about 101,128 (285)

Subgroups of the direct product of graphs of groups with free abelian vertex groups [PDF]

open access: yes, 2023
A result of Baumslag and Roseblade states that a finitely presented subgroup of the direct product of two free groups is virtually a direct product of free groups.
Zearra, Jone Lopez de Gamiz   +1 more
core   +1 more source

Interpreting the effects of DNA polymerase variants at the structural level

open access: yesMolecular Oncology, EarlyView.
Using MAVISp and molecular dynamics simulations, we analyzed over 60 000 missense variants in POLE and POLD1 from ClinVar, COSMIC, cBioPortal, and saturation mutagenesis. Identified mechanistic indicators, including stability, binding, and long‐range, enable structural interpretation, providing ACMG‐like evidence for possible reclassification of VUS ...
Matteo Arnaudi   +7 more
wiley   +1 more source

Median and quasi-median direct products of graphs [PDF]

open access: yes, 2005
Median graphs are characterized among direct products of graphs on at least three vertices. Beside some trivial cases, it is shown that one component of G×P₃ is median if and only if G is a tree in that the distance between any two vertices of degree at ...
Jha, Pranava   +3 more
core   +1 more source

A novel decision-making approach under spherical fuzzy environment

open access: yesInternational Journal of Mathematics for Industry
Health insurance is essential for protecting individuals from rising medical and hospitalization costs, offering crucial financial security, especially as choosing the right plan involves navigating numerous complex and uncertain factors.
Biswajit Some, Anita Pal
doaj   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

ON THE LAPLACIAN SPECTRA OF PRODUCT GRAPHS [PDF]

open access: yes, 2015
Graph products and their structural properties have been studied extensively by many researchers. We investigate the Laplacian eigenvalues and eigenvectors of the product graphs for the four standard products, namely, the Cartesian product, the direct ...
S Barik, S Pati, R B Bapat
core  

Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining

open access: yesMolecular Oncology, EarlyView.
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis   +3 more
wiley   +1 more source

2-Tone Colorings in Graph Products

open access: yesDiscussiones Mathematicae Graph Theory, 2015
A variation of graph coloring known as a t-tone k-coloring assigns a set of t colors to each vertex of a graph from the set {1, . . . , k}, where the sets of colors assigned to any two vertices distance d apart share fewer than d colors in common.
Loe Jennifer   +3 more
doaj   +1 more source

Finding novel vulnerabilities of hypomorphic BRCA1 alleles

open access: yesMolecular Oncology, EarlyView.
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder   +10 more
wiley   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy